{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T09:04:46Z","timestamp":1776503086799,"version":"3.51.2"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,12,8]],"date-time":"2013-12-08T00:00:00Z","timestamp":1386460800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1007\/s13277-013-1378-7","type":"journal-article","created":{"date-parts":[[2013,12,7]],"date-time":"2013-12-07T03:48:01Z","timestamp":1386388081000},"page":"2941-2948","source":"Crossref","is-referenced-by-count":16,"title":["Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy"],"prefix":"10.1007","volume":"35","author":[{"given":"Zheng-mao","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-hang","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-ming","family":"Nie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-en","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li-ye","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-chao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chong-we","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-wei","family":"Bi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,8]]},"reference":[{"key":"1378_CR1","unstructured":"International Agency for Research on Cancer. Globocan 2008: stomach cancer incidence, mortality and prevalence worldwide in 2008. IARC. 2008"},{"key":"1378_CR2","first-page":"S4","volume":"54","author":"JS Macdonald","year":"2004","unstructured":"Macdonald JS. Clinical overview: adjuvant therapy of gastrointestinal cancer. Cancer Chemother Pharmacol. 2004;54:S4\u2013S11.","journal-title":"Cancer Chemother Pharmacol"},{"key":"1378_CR3","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1093\/annonc\/mdh422","volume":"15","author":"SS Wohrer","year":"2004","unstructured":"Wohrer SS, Raderer M, Hejna M. Palliative chemotherapy for advanced gastric cancer. Ann Oncol. 2004;15:1585\u201395.","journal-title":"Ann Oncol"},{"issue":"10","key":"1378_CR4","first-page":"3543","volume":"31","author":"F Pasini","year":"2011","unstructured":"Pasini F, Fraccon AP, DEM G. The role of chemotherapy in metastatic gastric cancer. Anticancer Res. 2011;31(10):3543\u201354.","journal-title":"Anticancer Res"},{"key":"1378_CR5","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1080\/02841860600791483","volume":"46","author":"SY Oh","year":"2007","unstructured":"Oh SY, Kwon HC, Seo BG, Kim SH, Kim JS, Kim HJ. A phase II study of oxaliplatin with low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFOX-4) as first line therapy for patients with advanced gastric cancer. Acta Oncol. 2007;46:336\u201341.","journal-title":"Acta Oncol"},{"key":"1378_CR6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4143\/crt.2010.42.1.24","volume":"42","author":"YS Kim","year":"2010","unstructured":"Kim YS, Hong J, Sym SJ, et al. Oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX-4) combination chemotherapy as a salvage treatment in advanced gastric cancer. Cancer Res Treat. 2010;42:24\u20139.","journal-title":"Cancer Res Treat"},{"key":"1378_CR7","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1126\/science.1056154","volume":"291","author":"RD Wood","year":"2001","unstructured":"Wood RD, Mitchell M, Sgouros J, Lindahl T. Human DNA repair genes. Science. 2001;291:1284\u20139.","journal-title":"Science"},{"key":"1378_CR8","doi-asserted-by":"crossref","first-page":"7980","DOI":"10.1128\/MCB.20.21.7980-7990.2000","volume":"20","author":"IU Silva De","year":"2000","unstructured":"De Silva IU, McHugh PJ, Clingen PH, Hartley JA. Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol Cell Biol. 2000;20:7980\u201390.","journal-title":"Mol Cell Biol"},{"key":"1378_CR9","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/35094000","volume":"1","author":"EC Friedberg","year":"2001","unstructured":"Friedberg EC. How nucleotide excision repair protects against cancer. Nat Rev Cancer. 2001;1:22\u201333.","journal-title":"Nat Rev Cancer"},{"key":"1378_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0923-1811(99)00088-2","volume":"23","author":"JE Cleaver","year":"2000","unstructured":"Cleaver JE. Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum. J Dermatol Sci. 2000;23:1\u201311.","journal-title":"J Dermatol Sci"},{"key":"1378_CR11","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.1074\/jbc.271.14.8285","volume":"271","author":"D Mu","year":"1996","unstructured":"Mu D, Hsu DS, Sancar A. Reaction mechanism of human DNA repair excision nuclease. J Biol Chem. 1996;271:8285\u201394.","journal-title":"J Biol Chem"},{"key":"1378_CR12","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1126\/science.7801120","volume":"266","author":"A Sancar","year":"1994","unstructured":"Sancar A. Mechanisms of DNA excision repair. Science. 1994;266:1954\u201368.","journal-title":"Science"},{"key":"1378_CR13","doi-asserted-by":"crossref","first-page":"10004","DOI":"10.1021\/bi960453+","volume":"35","author":"DB Zamble","year":"1996","unstructured":"Zamble DB, Mu D, Reardon JT, Sancar A, Lippard SJ. Repair of cisplatin-DNA adducts by the mammalian excision nuclease. Biochemistry. 1996;35:10004\u201313.","journal-title":"Biochemistry"},{"key":"1378_CR14","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1470-2045(01)00454-5","volume":"2","author":"PJ McHugh","year":"2001","unstructured":"McHugh PJ, Spanswick VJ, Hartley JA. Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance. Lancet Oncol. 2001;2:483\u201390.","journal-title":"Lancet Oncol"},{"key":"1378_CR15","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.ygyno.2012.05.006","volume":"126","author":"JA Deloia","year":"2012","unstructured":"Deloia JA, Bhagwat NR, Darcy KM, Strange M, Tian C, Nuttall K, et al. Comparison of ERCC1\/XPF genetic variation, mRNA and protein levels in women with advanced stage ovarian cancer treated with intraperitoneal platinum. Gynecol Oncol. 2012;126:448\u201354.","journal-title":"Gynecol Oncol"},{"key":"1378_CR16","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/sj.bjc.6605686","volume":"102","author":"KR Fareed","year":"2010","unstructured":"Fareed KR, Al-Attar A, Soomro IN, Kaye PV, Patel J, Lobo DN, et al. Tumour regression and ERCC1 nuclear protein expression predict clinical outcome in patients with gastro-oesophageal cancer treated with neoadjuvant chemotherapy. Br J Cancer. 2010;102:1600\u20137.","journal-title":"Br J Cancer"},{"key":"1378_CR17","doi-asserted-by":"crossref","first-page":"5513","DOI":"10.1158\/1078-0432.CCR-11-0086","volume":"1","author":"A Vaezi","year":"2011","unstructured":"Vaezi A, Wang X, Buch S, Gooding W, Wang L, Seethala RR, et al. XPF expression correlates with clinical outcome in squamous cell carcinoma of the head and neck. Clin Cancer Res. 2011;1:5513\u201322. 2011.","journal-title":"Clin Cancer Res"},{"key":"1378_CR18","doi-asserted-by":"crossref","first-page":"5796","DOI":"10.1158\/1078-0432.CCR-10-0292","volume":"16","author":"BM Alexander","year":"2010","unstructured":"Alexander BM, Sprott K, Farrow DA, Wang X, D\u2019Andrea AD, Schnitt SJ, et al. DNA repair protein biomarkers associated with time to recurrence in triple-negative breast cancer. Clin Cancer Res. 2010;16:5796\u2013804.","journal-title":"Clin Cancer Res"},{"key":"1378_CR19","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"AB Miller","year":"1981","unstructured":"Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47:207\u201314.","journal-title":"Cancer"},{"key":"1378_CR20","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1089\/gtmb.2013.0122","volume":"17","author":"Z Yang","year":"2013","unstructured":"Yang Z, Fang X, Pei X, Li H. Polymorphisms in the ERCC1 and XPF genes and risk of breast cancer in a Chinese population. Genet Test Mol Biomark. 2013;17:700\u20136.","journal-title":"Genet Test Mol Biomark"},{"issue":"1","key":"1378_CR21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/mutage\/gen052","volume":"24","author":"A Mohseni-Meybodi","year":"2009","unstructured":"Mohseni-Meybodi A, Mozdarani H, Mozdarani S. DNA damage and repair of leukocytes from Fanconi anaemia patients, carriers and healthy individuals as measured by the alkaline comet assay. Mutagenesis. 2009;24(1):67\u201373.","journal-title":"Mutagenesis"},{"key":"1378_CR22","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1126\/science.1182372","volume":"326","author":"P Knipscheer","year":"2009","unstructured":"Knipscheer P, Raschle M, Smogorzewska A, Enoiu M, Ho TV, Scharer OD, et al. The Fanconi anemia pathway promotes replication-dependent DNA interstrand cross-link repair. Science. 2009;326:1698\u2013701.","journal-title":"Science"},{"key":"1378_CR23","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1126\/science.1192656","volume":"329","author":"T Liu","year":"2010","unstructured":"Liu T, Ghosal G, Yuan J, Chen J, Huang J. FAN1 acts with FANCI-FANCD2 to promote DNA interstrand cross-link repair. Science. 2010;329:693\u20136.","journal-title":"Science"},{"key":"1378_CR24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.gene.2013.05.021","volume":"526","author":"TP Xu","year":"2013","unstructured":"Xu TP, Shen H, Liu LX, Shu YQ. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports. Gene. 2013;526:265\u201374.","journal-title":"Gene"},{"key":"1378_CR25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00280-013-2196-8","volume":"72","author":"C Chen","year":"2013","unstructured":"Chen C, Wang F, Wang Z, Li C, Luo H, Liang Y, et al. Polymorphisms in ERCC1 C8092A predict progression-free survival in metastatic\/recurrent nasopharyngeal carcinoma treated with cisplatin-based chemotherapy. Cancer Chemother Pharmacol. 2013;72:315\u201322.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"1378_CR26","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.prp.2013.02.009","volume":"209","author":"R Gerhard","year":"2013","unstructured":"Gerhard R, Carvalho A, Carneiro V, Bento RS, Uemura G, Gomes M, et al. Clinicopathological significance of ERCC1 expression in breast cancer. Pathol Res Pract. 2013;209(6):331\u20136.","journal-title":"Pathol Res Pract"},{"issue":"4","key":"1378_CR27","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/mutage\/get023","volume":"28","author":"H Chu","year":"2013","unstructured":"Chu H, Gu D, Xu M, Xu Z, Gong Y, Gong W, et al. A genetic variant in ERCC2 is associated with gastric cancer prognosis in a Chinese population. Mutagenesis. 2013;28(4):441\u20136.","journal-title":"Mutagenesis"},{"key":"1378_CR28","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.7314\/APJCP.2012.13.5.1799","volume":"13","author":"SY He","year":"2012","unstructured":"He SY, Xu L, Niu G, Ke PQ, Feng MM, Shen HW. Predictive value of excision repair cross-complementing rodent repair deficiency complementation group 1 and ovarian cancer risk. Asian Pac J Cancer Prev. 2012;13:1799\u2013802.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1378_CR29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1471-230X-12-137","volume":"12","author":"Z Wang","year":"2012","unstructured":"Wang Z, Chen JQ, Liu JL, Qin XG, Huang Y. Polymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum\/5-Fu-based chemotherapy: a systematic review. BMC Gastroenterol. 2012;12:137.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"1378_CR30","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3892\/ol.2012.1096","volume":"5","author":"YP Liu","year":"2013","unstructured":"Liu YP, Ling Y, Qi QF, Zhang YP, Zhang CS, Zhu CT, et al. The effects of ERCC1 expression levels on the chemosensitivity of gastric cancer cells to platinum agents and survival in gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy. Oncol Lett. 2013;5(3):935\u201342.","journal-title":"Oncol Lett"},{"issue":"6","key":"1378_CR31","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.3892\/mmr.2013.1435","volume":"7","author":"YP Liu","year":"2013","unstructured":"Liu YP, Ling Y, Qi QF, Zhang YP, Zhang CS, Zhu CT, et al. Genetic polymorphisms of ERCC1-118, XRCC1-399 and GSTP1-105 are associated with the clinical outcome of gastric cancer patients receiving oxaliplatin-based adjuvant chemotherapy. Mol Med Rep. 2013;7(6):1904\u201311.","journal-title":"Mol Med Rep"},{"key":"1378_CR32","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/ijc.23852","volume":"124","author":"B Gustavsson","year":"2009","unstructured":"Gustavsson B, Kaiser C, Carlsson G, Wettergren Y, Odin E, Lindskog EB, et al. Molecular determinants of efficacy for 5-FU-based treatments in advanced colorectal cancer: mRNA expression for 18 chemotherapy-related genes. Int J Cancer. 2009;124:1220\u20136.","journal-title":"Int J Cancer"},{"key":"1378_CR33","first-page":"515","volume":"32","author":"J Liang","year":"2010","unstructured":"Liang J, Li QF, Yao RY, L\u00fc HY, Jiang J, Sun YY, et al. Association between genetic polymorphisms of ERCC1, XRCC1, GSTP1 and survival of advanced gastric cancer patients treated with oxaliplatin\/5-Fu-based chemotherapy. Zhonghua Zhong Liu Za Zhi. 2010;32:515\u20139.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"1378_CR34","first-page":"1513","volume":"11","author":"EL Goode","year":"2002","unstructured":"Goode EL, Ulrich MC, Potter JD. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomark Prev. 2002;11:1513\u201330.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1378_CR35","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0305-7372(98)90056-1","volume":"24","author":"E Reed","year":"1998","unstructured":"Reed E. Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy. Cancer Treat Rev. 1998;24:331\u201344.","journal-title":"Cancer Treat Rev"},{"key":"1378_CR36","doi-asserted-by":"crossref","first-page":"e49308","DOI":"10.1371\/journal.pone.0049308","volume":"7","author":"J He","year":"2012","unstructured":"He J, Xu Y, Qiu LX, Li J, Zhou XY, Sun MH, et al. Polymorphisms in ERCC1 and XPF genes and risk of gastric cancer in an eastern Chinese population. PLoS One. 2012;7:e49308.","journal-title":"PLoS One"},{"key":"1378_CR37","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/mutage\/geq042","volume":"25","author":"D Palli","year":"2010","unstructured":"Palli D, Polidoro S, D\u2019Errico M, Saieva C, Guarrera S, Calcagnile AS, et al. Polymorphic DNA repair and metabolic genes: a multigenic study on gastric cancer. Mutagenesis. 2010;25:569\u201375.","journal-title":"Mutagenesis"},{"key":"1378_CR38","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/bjc.2013.127","volume":"108","author":"M Tiseo","year":"2013","unstructured":"Tiseo M, Bordi P, Bortesi B, Boni L, Boni C, Baldini E, et al. Bio-FAST trial group: ERCC1\/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin. Br J Cancer. 2013;108:1695\u2013703.","journal-title":"Br J Cancer"},{"key":"1378_CR39","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.clcc.2012.11.006","volume":"12","author":"C Arienti","year":"2013","unstructured":"Arienti C, Tesei A, Verdecchia GM, Framarini M, Virz\u00ec S, Grassi A, et al. Role of conventional chemosensitivity test and tissue biomarker expression in predicting response to treatment of peritoneal carcinomatosis from colon cancer. Clin Colorectal Cancer. 2013;12:122\u20137.","journal-title":"Clin Colorectal Cancer"},{"key":"1378_CR40","doi-asserted-by":"crossref","first-page":"5883","DOI":"10.7314\/APJCP.2012.13.11.5883","volume":"13","author":"LM Yang","year":"2012","unstructured":"Yang LM, Li XH, Bao CF. Glutathione S-transferase P1 and DNA polymorphisms influence response to chemotherapy and prognosis of bone tumors. Asian Pac J Cancer Prev. 2012;13:5883\u20136.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1378_CR41","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1158\/1078-0432.CCR-10-2169","volume":"17","author":"M Yin","year":"2011","unstructured":"Yin M, Yan J, Martinez-Balibrea E, Graziano F, Lenz HJ, Kim HJ, et al. ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis. Clin Cancer Res. 2011;17:1632\u201340.","journal-title":"Clin Cancer Res"},{"key":"1378_CR42","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/carcin\/bgr258","volume":"33","author":"KH Barry","year":"2012","unstructured":"Barry KH, Koutros S, Andreotti G, Sandler DP, Burdette LA, Yeager M, et al. Genetic variation in nucleotide excision repair pathway genes, pesticide exposure and prostate cancer risk. Carcinogenesis. 2012;33:331\u20137.","journal-title":"Carcinogenesis"},{"key":"1378_CR43","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S1097-2765(03)00478-7","volume":"12","author":"XD Zhu","year":"2003","unstructured":"Zhu XD, Niedernhofer L, Kuster B, Mann M, Hoeijmakers JH, de Lange T. ERCC1\/XPF removes the 3\u2032 overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol Cell. 2003;12:1489\u201398.","journal-title":"Mol Cell"},{"key":"1378_CR44","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.ijrobp.2004.11.026","volume":"62","author":"DG Kornguth","year":"2005","unstructured":"Kornguth DG, Garden AS, Zheng Y, Dahlstrom KR, Wei Q, Sturgis EM. Gastrostomy in oropharyngeal cancer patients with ERCC4 (XPF) germline variants. Int J Radiat Oncol Biol Phys. 2005;62:665\u201371.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1378_CR45","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/sj.bjc.6604211","volume":"98","author":"J Matsubara","year":"2008","unstructured":"Matsubara J, Nishina T, Yamada Y, Moriwaki T, Shimoda T, Kajiwara T, et al. Impacts of excision repair cross-complementing gene 1 (ERCC1), dihydropyrimidine dehydrogenase, and epidermal growth factor receptor on the outcomes of patients with advanced gastric cancer. Br J Cancer. 2008;98:832\u20139.","journal-title":"Br J Cancer"},{"key":"1378_CR46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2407-8-97","volume":"8","author":"L Wang","year":"2008","unstructured":"Wang L, Wei J, Qian X, Yin H, Zhao Y, Yu L, et al. ERCC1 and BRCA1 mRNA expression levels in metastatic malignant effusions is associated with chemosensitivity to cisplatin and\/or docetaxel. BMC Cancer. 2008;8:97.","journal-title":"BMC Cancer"},{"key":"1378_CR47","first-page":"181","volume":"11","author":"M Ozkan","year":"2010","unstructured":"Ozkan M, Akbudak IH, Deniz K, Dikilitas M, Dogu GG, Berk V, et al. Prognostic value of excision repair cross-complementing gene 1 expression for cisplatin-based chemotherapy in advanced gastric cancer. Asian Pac J Cancer Prev. 2010;11:181\u20135.","journal-title":"Asian Pac J Cancer Prev"},{"key":"1378_CR48","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4143\/crt.2010.42.2.101","volume":"42","author":"J Yun","year":"2010","unstructured":"Yun J, Kim KM, Kim ST, Kim JH, Kim JA, Kong JH, et al. Predictive value of the ERCC1 expression for treatment response and survival in advanced gastric cancer patients receiving cisplatin-based first-line chemotherapy. Cancer Res Treat. 2010;42:101\u20136.","journal-title":"Cancer Res Treat"},{"key":"1378_CR49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mrfmmm.2011.05.003","volume":"713","author":"J Yin","year":"2011","unstructured":"Yin J, Vogel U, Ma Y, Qi R, Wang H, Yue L, et al. HapMap-based study of a region encompassing ERCC1 and ERCC2 related to lung cancer susceptibility in a Chinese population. Mutat Res. 2011;713:1\u20137.","journal-title":"Mutat Res"},{"key":"1378_CR50","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijrobp.2011.05.033","volume":"83","author":"BM Alexander","year":"2012","unstructured":"Alexander BM, Wang XZ, Niemierko A, Weaver DT, Mak RH, Roof KS, et al. DNA repair biomarkers predict response to neoadjuvant chemoradiotherapy in esophageal cancer. Int J Radiat Oncol Biol Phys. 2012;83:164\u201371.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-013-1378-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-013-1378-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-013-1378-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,4]],"date-time":"2019-08-04T16:33:34Z","timestamp":1564936414000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-013-1378-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,8]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["1378"],"URL":"https:\/\/doi.org\/10.1007\/s13277-013-1378-7","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,8]]}}}